Original Article

Prevalence and Trends of Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease among Adults in the United States

Objectives: Metabolic dysfunction–associated steatotic liver disease (MASLD) affects approximately 100 million individuals in the United States. Previous studies have reported a significant association between obesity and MASLD. The objective of our study was to examine the relationship between obesity and population-level trends in MASLD prevalence among US adults aged 20…